Viewing Study NCT01125618



Ignite Creation Date: 2024-05-05 @ 10:29 PM
Last Modification Date: 2024-10-26 @ 10:20 AM
Study NCT ID: NCT01125618
Status: COMPLETED
Last Update Posted: 2017-04-21
First Post: 2010-05-12

Brief Title: Millennium Villages Project in Sub-Saharan Africa
Sponsor: Columbia University
Organization: Columbia University

Study Overview

Official Title: A Pair-matched Community Intervention Trial to Assess the Impact of an Integrated Health and Development Intervention on Child Survival and the Millennium Development Goals in 10 Sub- Saharan African Countries
Status: COMPLETED
Status Verified Date: 2017-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: MVP
Brief Summary: The Millennium Villages Project involves the coordinated and simultaneous delivery of a package of proven interventions in health agriculture infrastructure and education The project works in partnership with governments in 10 African countries in areas where progress towards achieving the Millennium Development Goals has been insufficient

The Project evaluation will test the following hypotheses

1 That after 5 years of operation villages exposed to the MVP intervention will have a lower rate of under-5 mortality and parallel gains in MDG-related secondary outcomes when compared to similar villages not receiving the intervention
2 That the coordinated delivery a multi-sector package of health and development interventions implemented through a broad-based local partnership is feasible in a diversity of sub-Saharan African contexts and
3 The intervention package can be delivered at a scalable cost of 40 per person per year in the health sector and 110 per person per year in total
Detailed Description: Design and population The design is a pair-matched community intervention trial Village clusters with high levels of malnutrition were selected from rural areas in ten sub-Saharan African countries to reflect a diverse range of agro-ecological zones farming systems disease profiles and infrastructure challenges MVP sites represent 80 villages in 14 clusters across 10 countries covering nearly 500000 people For each intervention cluster a matched comparison cluster has been selected at random to participate in the evaluation

Outcomes The primary outcome is the under-5 mortality rate Secondary outcomes are levels of coverage with essential maternal-child health interventions and related MDG indicators for poverty nutrition education and environmental health

Sample size calculation The assessment follows 6000 households across intervention and matched comparison villages at baseline and after 3 and 5 years of intervention exposure With 10 paired clusters the study is powered to detect a 40 difference in the U5MR between the two groups

Analysis plan The analysis will use a two-staged pair-matched cluster level analysis and will be complemented with multilevel modeling Reporting will adhere to Transparent Reporting of Evaluations with Non-randomized Designs TREND guidelines

Implementation science A portfolio of qualitative implementation science process evaluation will complement the quantitative assessment and involves interviews with implementers partners and project beneficiaries This analysis will address questions about the feasibility of the interventions the timing and sequence of their introduction key contextual barriers and facilitators to implementation and potential synergies achieved from the integrated multisector approach

Economic costing study One project hypothesis is that an annual per capita investment of 110 is required to achieve the MDGs The aim of the economic costing study is to document the absolute and relative contribution of project partners MVP government donors and the community to all priced and non-priced cluster-level activities as well as the sector-specific breakdown of these inputs

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None